Application of Recombinant DNA in Gene Therapy: SARS-CoV-2 DNA Vaccine and Cancer Therapy

Authors

  • Rofi Yoga Ardandi Medical Faculty, Lampung University
  • Suci Nurhaliza Medical Faculty, Lampung University
  • Pitha Maykania Poty Medical Faculty, Lampung University
  • Nindy Putri Sha Medical Faculty, Lampung University
  • Soraya Rahmanisa Fakultas Kedokteran, Universitas Lampung

DOI:

https://doi.org/10.53089/medula.v14i5.930

Keywords:

Recombinant DNA, gene therapy, vaccine, cancer

Abstract

Recombinant DNA technology is the fusion of genetic material from two different sources. Recombinant DNA refers to combining genetic material from two different sources to create a new organism or to produce a specific protein. The main purpose of genetic recombination is to produce more evolved and adapted organisms, as well as develop biotechnology strategies, such as recombinant protein production. This technology is applied in clinical and medicine such as vaccines. Recombinant vaccines are made by utilizing recombinant DNA technology, which is a gene cloning technique that is modified to produce the specific protein product sought. Gene cloning is a procedure by which foreign DNA or genes are inserted into a host cell using a vector. Gene cloning involves the insertion of a gene of interest into a vector, resulting in the creation of recombinant DNA that can replicate within the host cell, an example being the SARS-CoV-2 DNA vaccine. Oncolytic virus, Gendicine, Modified Virus Ankara (MVA) are recombinant DNA technologies for cancer therapy. The advantages of this therapy are its ability to form new combinations of genetic material by insertion of molecules; DNA recombination technology allows the production of large quantities of certain protein molecules, which can be used in the manufacture of drugs; the production of therapeutic substances by strains of organisms can be achieved through the use of recombinant DNA technology; drugs that have unique properties that are difficult or impossible to obtain through traditional approaches can be made through DNA recombination; and DNA recombination plays an important role in drug manufacturing by facilitating the synthesis of therapeutic molecules important for human health. The disadvantages are that it has a negative impact on the environment, requires strict supervision to ensure safety and security, and ethical controversies. This technology has many benefits, but it is necessary to consider some of the disadvantages and adverse effects that can be caused.

References

Apolonio JS, Goncalves VLS, Santos MLC, Luz MS, Souza JCS, Pinheiro SLR. Oncolytic virus therapy in cancer: A current review. World Journal of Virology [Internet]. 2021 [disitasi tanggal 21 Desember 2023]; 10(5): 229–255. Tersedia dari: https://doi.org/10.5501/wjv.v10.i5.229

Belete TM. The current status of gene therapy for the treatment of cancer. Biologics: Targets and Therapy [Internet]. 2021 [disitasi tanggal 22 Desember 2023; 15:67–77. Tersedia dari: https://doi.org/10.2147/BTT.S302095

Bendjama K, Quemeneur E. Modified Vaccinia virus Ankara-based vaccines in the era of personalized immunotherapy of cancer. Human Vaccines and Immunotherapeutics [Internet]. 2017 [disitasi tanggal 19 Desember 2023]; 13(9). Tersedia dari: https://doi.org/10.1080/21645515.2017.1334746

Gordon SV, Yimenu D, Demissie A, Ameni G, Aseffa A, Tschopp R, dkk. Ismael Special Issue on Bovine Tuberculosis in Ethiopia. 2009.

Khalid K, Poh CL. The development of DNA vaccines against SARS-CoV-2. Advances in medical sciences [Internet]. 2023 [disitasi tanggal 21 Desember 2023]; 68(2): 213–226. Tersedia dari: https://doi.org/10.1016/j.advms.2023.05.003

Khan S, Ullah MW, Siddique R, Nabi G, Manan S, Yousaf M, dkk. Role of Recombinant DNA Technology to Improve Life. International journal of genomics [Internet]. 2016 [disitasi tanggal 21 Desember 2023]; 2405954. Tersedia dari: https://doi.org/10.1155/2016/2405954

Susmiarsih TP. Kajian DNA Rekombinan pada Vaksin DNA dan Vaksin Subunit Protein. Majalah Kesehatan PharmaMedika. 2018; 10(2): 108-128.

Tajuddin T. Bioteknologi. Edisi ke-2. Tangerang Selatan: Universitas Terbuka. 2021.

Vipra M, Patil N, Sivaram A. Applicationts of Recombinant DNA Technology. In: Kalyuzhny AE, editor. A Complete Guide to Gene Cloning: From Basic to Advanced. Cham: Springer; 2022. p. 143-57.

Zhang Y, Wang X. Targeting the Wnt/β-catenin signaling pathway in cancer. Journal of Hematology and Oncology [Internet]. 2020 [disitasi tanggal 21 Desember 2023]; 13(1). Tersedia dari: https://doi.org/10.1186/s13045-020-00990-3

Published

2024-06-18

How to Cite

Ardandi, R. Y., Nurhaliza, S., Poty, P. M., Sha, N. P., & Rahmanisa, S. (2024). Application of Recombinant DNA in Gene Therapy: SARS-CoV-2 DNA Vaccine and Cancer Therapy. Medical Profession Journal of Lampung, 14(5), 895-900. https://doi.org/10.53089/medula.v14i5.930

Issue

Section

Artikel

Most read articles by the same author(s)